The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study

  • Ann Marie McNeill
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Wayne D. Rosamond
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  • Cynthia J. Girman
    Department of Epidemiology, Merck Research Laboratories, Rahway, New Jersey
  • Sherita Hill Golden
    Department of Medicine, Johns Hopkins University School of Medicine and Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland
  • Maria I. Schmidt
    Graduate Studies Program in Epidemiology, Federal University of Rio Grande do Sul, Porto Alegre, Brazil
  • Honey E. East
    Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi
  • Christie M. Ballantyne
    Methodist DeBakey Heart Center and Department of Medicine, Baylor College of Medicine, Houston, Texas
  • Gerardo Heiss
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

抄録

<jats:p>OBJECTIVE— To assess the magnitude of the association between the National Cholesterol Education Program’s Third Adult Treatment Panel Report (ATP III) definition of the metabolic syndrome and cardiovascular disease (CVD).</jats:p> <jats:p>RESEARCH DESIGN AND METHODS— Cox regression was used to estimate the relative risk of incident coronary heart disease (CHD) and stroke among 12,089 black and white middle-aged individuals in the Atherosclerosis Risk in Communities (ARIC) study.</jats:p> <jats:p>RESULTS— The metabolic syndrome was present in ∼23% of individuals without diabetes or prevalent CVD at baseline. Over an average of 11 years of follow-up, 879 incident CHD and 216 ischemic stroke events occurred. Among the components of the metabolic syndrome, elevated blood pressure and low levels of HDL cholesterol exhibited the strongest associations with CHD. Men and women with the metabolic syndrome were ∼1.5 and 2 times more likely to develop CHD than control subjects after adjustment for age, smoking, LDL cholesterol, and race/ARIC center (sex interaction P &lt; 0.03). Similar associations were found between the metabolic syndrome and incident ischemic stroke. Comparison of receiver operating characteristic curves indicated that the metabolic syndrome did not materially improve CHD risk prediction beyond the level achieved by the Framingham Risk Score (FRS).</jats:p> <jats:p>CONCLUSIONS— Individuals without diabetes or CVD, but with the metabolic syndrome, were at increased risk for long-term cardiovascular outcomes, although statistical models suggested that most of that risk was accounted for by the FRS. Nevertheless, identification of individuals with the metabolic syndrome may provide opportunities to intervene earlier in the development of shared disease pathways that predispose individuals to both CVD and diabetes.</jats:p>

収録刊行物

  • Diabetes Care

    Diabetes Care 28 (2), 385-390, 2005-02-01

    American Diabetes Association

被引用文献 (39)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ